GCT
ABBV icon

Galaxy Capital Trading’s AbbVie ABBV Stock Holding History

Galaxy Capital Trading’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$201K Sell
3,800
-5,000
-57% -$246K 0.5% 66
2013
Q3 		$394K Buy
+8,800
New +$390K 0.3% 116

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Galaxy Capital Trading's ABBV Position: Q4 2013 in Review

Galaxy Capital Trading reduced its AbbVie (ABBV) stake by 57% in Q4 2013, selling an estimated $246K and leaving 3,800 shares worth $201K. The position accounts for 0.5% of the portfolio, ranked #66.

Galaxy Capital Trading first reported a position in ABBV in Q3 2013 and has held it in 2 quarters since. The position peaked at $394K in Q3 2013. 1,433 funds tracked by Wall St. Rank hold ABBV as of Q4 2013.

  • Galaxy Capital Trading held 3,800 shares of AbbVie worth $201K as of Q4 2013.
  • Galaxy Capital Trading sold 5,000 AbbVie shares in Q4 2013, an estimated $246K.
  • AbbVie made up 0.5% of Galaxy Capital Trading's portfolio in Q4 2013, its #66 holding.
  • Galaxy Capital Trading first reported a position in AbbVie in Q3 2013 and has held it in 2 quarters since.
  • Galaxy Capital Trading's AbbVie position peaked at $394K in Q3 2013.
  • 1,433 funds tracked by Wall St. Rank held AbbVie as of Q4 2013.

Based on Galaxy Capital Trading's 13F filing for Q4 2013, filed 26 Feb 2014.